ImmuneSpec offers a state-of-the-art immunopeptidomics platform designed to advance immunogenicity testing by precisely identifying and characterizing immunogenic peptides. Leveraging a mass spectrometry (MS)-based approach, our platform provides unmatched accuracy and depth in profiling peptides presented by MHC molecules.
By delivering comprehensive and unbiased analysis of the immunopeptidome, our platform identifies immunogenic regions within biotherapeutics, enabling the optimization of designs to reduce potential immunogenicity risks. This enhances safety profiles and improves therapeutic efficacy.
Additionally, the platform facilitates the discovery of rare neoepitopes and mutation-derived peptides, offering critical insights to support the development of next-generation immunotherapies and innovative vaccines.
